Roche has said it plans to UK price ts latest multiple sclerosis drug Ocrevus in line with its close rival from Novartis.

A subcutaneous (SC) injection version of Roche’s big-selling multiple sclerosis therapy Ocrevus has matched the current intravenous form in a clinical trial and, according to the company, could ...

Kesimpta, which is used to treat multiple sclerosis, can cause side effects. Learn about its mild and serious side effects and how to manage them.

Best International Companies to Own: 2025 Edition These companies from various corners of the globe are well positioned for the future.

Find the latest Halozyme Therapeutics, Inc. (HALO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.

Margarida Maia is a science writer for Multiple Sclerosis News Today with a PhD in biomedical sciences. She covers the latest news and information on a variety of multiple sclerosis topics.